NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-235-2010-0-US-06 Amido Compounds As RORyt Modulators and Uses Thereof US CON 15/350,299 10561666 Issued PDF
NCI E-139-2015-0-EP-03 FIXATIVES AND METHODS OF USE EP National Stage 16809238.5 Issued
NCI E-139-2015-0-GB-01 FIXATIVES AND METHODS OF USE GB EP 16809238.5 Issued
NCI E-139-2015-0-DE-01 FIXATIVES AND METHODS OF USE DE EP 16809238.5 Issued
NCI E-139-2015-0-FR-01 FIXATIVES AND METHODS OF USE FR EP 16809238.5 Issued
NINDS E-121-2014-0-JP-05 Miniature Serial Sectioning Microtome For Block-face Imaging JP National Stage 2016-567624 Abandoned
NCI E-139-2015-0-PCT-02 FIXATIVES AND METHODS OF USE PCT PCT PCT/US2016/061642 Expired
NCI E-025-2009-0-US-28 Ratio Based Biomarkers and Methods of Use Thereof US CON 15/349,991 Abandoned
NIMH E-259-2016-0-US-01 Radiolabeling Agents, Methods of Making, and Methods of Use Thereof US 62/420,840 Abandoned
NCI E-010-2016-2-PCT-01 Anti-BCMA Polypeptides and Proteins PCT PCT COMB PCT/US2016/061320 Expired
NIAID E-053-2018-0-US-01 Methods Of Treating And Inhibiting Ebola Virus Infection US 62/420,474 Abandoned
NCI E-010-2016-2-CA-03 Anti-BCMA Polypeptides and Proteins CA National Stage 3005042 Pending
NCI E-010-2016-2-IN-06 Anti-BCMA Polypeptides and Proteins IN National Stage 201847017742 Abandoned
NIA E-205-2006-2-US-22 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US CON 15/347,354 9908841 Issued PDF
NEI E-293-2016-0-US-01 Tissue Clamp and Implantation Method US 62/419,804 Abandoned
NEI E-004-2017-0-US-01 3D Vascularized Human Ocular Tissue For Cell Therapy And Drug Discovery US 62/419,835 Abandoned
NCI E-285-2016-2-AU-02 Glypican 2 As A Cancer Marker And Therapeutic Target AU National Stage 2016354440 Issued
NCI E-285-2016-2-PCT-01 Glypican 2 As A Cancer Marker And Therapeutic Target PCT PCT PCT/US2016/060974 Expired
NCI E-234-2010-1-US-08 Biomarkers For Prostate Cancer And Methods For Their Detection. US CON 15/345,634 Abandoned
NCI E-285-2016-2-CA-03 Glypican 2 As A Cancer Marker And Therapeutic Target CA National Stage 3004438 Pending
NCI E-176-2014-0-IL-08 Anti-Human Papillomavirus 16 E7 T Cell Receptors IL National Stage 248797 Issued
NINDS E-122-2014-0-US-03 Negative Resistance Preamplifier for Inductively Coupled Local MRI Coils US National Stage 15/309,336 10393831 Issued PDF
NHLBI E-034-2016-1-US-01 TSLP Induces Neutrophil Mediated Killing Of Methicillin-resistant Staphylococcus Aureus US ORD 15/345,213 10201591 Issued PDF
NICHD E-210-2021-0-PCT-02 Kits And Methods For Predictions And Treatment Of Preeclampsia PCT PCT PCT/US2016/060825 Expired
NICHD E-209-2021-0-PCT-02 Kits And Methods To Distinguish False Labor And True Labor PCT PCT PCT/US2016/060819 Expired
NCI E-169-2016-0-US-01 Development Of Agonist Epitopes Of The Human Papillomavirus US 62/497,064 Abandoned
NCI E-022-2017-0-US-01 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US 62/418,461 Abandoned
NCI E-015-2018-1-BR-01 Periodontitis Treatment BR ORD BR1020160262569 Pending
NCI E-055-2017-0-CN-03 Combing D2C7 Immunotoxin With Check Points Inhibitors CN National Stage 201680070875.6 Issued
NCI E-055-2017-0-FR-10 Combing D2C7 Immunotoxin With Check Points Inhibitors FR EP 16863025.9 Issued
NCI E-055-2017-0-DE-09 Combing D2C7 Immunotoxin With Check Points Inhibitors DE EP 16863025.9 Issued
NCI E-055-2017-0-GB-11 Combing D2C7 Immunotoxin With Check Points Inhibitors GB EP 16863025.9 Issued
NCI E-055-2017-0-EP-06 Combing D2C7 Immunotoxin With Check Points Inhibitors EP National Stage 16863025.9 Issued
NCI E-156-2014-0-US-03 Triggering RNA Interference With RNA-DNA And DNA-RNA Cube Nanoparticles US National Stage 15/309,157 10517890 Issued PDF
NCI E-055-2017-0-JP-04 Combing D2C7 Immunotoxin With Check Points Inhibitors JP National Stage 2018-543049 Issued
NIAID E-067-2016-3-PCT-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation PCT PCT COMB PCT/US2016/060672 Expired
NCI E-055-2017-0-PCT-02 Combing D2C7 Immunotoxin With Check Points Inhibitors PCT PCT PCT/US2016/060469 Expired
NIAID E-133-2015-0-AU-09 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE AU National Stage 2016349392 Issued
NIAID E-133-2015-0-CN-04 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CN National Stage 201680077520.X Issued
NIAID E-133-2015-0-PCT-02 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE PCT PCT PCT/US2016/060390 Expired
NIAID E-133-2015-0-EP-05 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE EP National Stage 16801639.2 Abandoned
NIAID E-133-2015-0-CA-03 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CA National Stage 3003878 Pending
NIAID E-133-2015-0-ZA-08 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE ZA National Stage 2018/02875 Pending
NLM E-107-2010-2-US-05 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US National Stage 15/341,344 10533213 Issued PDF
NINDS E-155-2006-0-US-14 Novel Neuroactive Steroids US CON 15/341,573 10087211 Issued PDF
NINDS E-121-2014-0-US-06 Miniature Serial Sectioning Microtome for Block-Face Imaging US National Stage 15/308,522 9933339 Abandoned PDF
NIA E-092-2011-0-US-09 THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND
OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE
IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN 		US CON 15/341,784 9867830 Issued PDF
NIDDK E-038-2016-0-PCT-02 IGF2BP1 AND/OR IGF2BP3 FOR TREATMENT PCT PCT PCT/US2016/060084 Expired
NHLBI E-211-2018-0-US-01 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US 62/416,241 Abandoned
NCI E-035-2016-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN INHIBITORS PCT PCT PCT/US2016/059834 Abandoned